Mr Alan Doherty

(Clinical Director)

Mr Alan Doherty is one of the UK’s most renowned prostate cancer specialists.

He has completed one of the largest caseloads of prostatectomies in the UK, undertaking more than 3,000 operations. He is recognised for his expertise in nerve-sparing techniques, reducing the risk of erectile dysfunction and incontinence from prostate cancer surgery. Mr Doherty has published extensive results from his nerve-sparing procedures. He was voted one of the UK’s top ten prostate cancer specialists in a national poll of consultant urologists published in the Daily Mail.

Mr Doherty came up with the original idea for, and led the development of, a live prostate cancer results centre allowing patients to track their individual recovery and compare outcomes in a clear and meaningful way. This innovation has been shortlisted for a prestigious Health Service Journal award.

Mr Doherty is a recognised UK expert in keyhole surgery, having performed more than 1,200 prostatectomies laparoscopically. Mr Doherty was also one of the first surgeons in the UK to perform laparoscopic cystectomy (bladder removal) and laparoscopic nephrectomy (kidney removal). Both procedures are acknowledged as being extremely technically demanding.

Mr Doherty also specialises in the treatment of benign prostatic hyperplasia (BPH), or the enlarged prostate, using GreenLight laser surgery, an effective, minimally-invasive treatment option. Mr Doherty has completed more than 500 GreenLight laser procedures, is a national trainer in the technique and is one of a small number of surgeons using the ‘third generation’ XPS laser technology.

Mr Doherty trained at The Middlesex Hospital, the Royal Marsden, Charing Cross Hospitals and the Institute of Urology before taking up his position as a consultant urologist at Queen Elizabeth Hospital Birmingham in 2001. He has published extensively, including articles inThe Lancet.

  • Prostate diagnosis and PSA
  • General urology and GreenLight laser for BPH
  • Prostate Cancer Treatment
Mr Alan Doherty, clinical director Birmingham Prostate Clinic

Mr Alan Doherty's Blog

Keith Padbury’s experience of the PCA3 test, a new genetics based assessment of prostate cancer risk
Keith Padbury was one of the first patients to have a PCA3 test, a new genetics based assessment of prostate cancer risk five years ago. He has benefitted from advanced assessments which mean unnecess ... Read More
BPC’s Paul Anderson is travelling to Zambia to train local surgeons in urethral stricture treatment
Birmingham Prostate Clinic surgeon is preparing for a trip to Zambia to train local surgeons in the treatment of urethral strictures. Mr Anderson will be travelling to Lusaka in Zambia in April, on ... Read More
Taking a Selenium supplement may increase your risk of prostate cancer and there is no proven benefit
By Dr Ahmed El-Modir After being diagnosed and treated for prostate cancer, patients often make lifestyle or diet changes they feel may be helpful. Of course we wholly recognise and support the ... Read More
View All Consultant Blogs